| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 05/23/2006 | US7049484 Commercial production of proteases in plants |
| 05/23/2006 | US7049427 From plants having decreased content of anthocyanins; enzyme inhibitors |
| 05/23/2006 | US7049424 Genes from the 20Q13 amplicon and their uses |
| 05/23/2006 | US7049421 Polynucleotide encoding a gene product having tricothecene resistance activity that thereby confers trichothecene resistance to transgenic plants, plant tissues, plant seeds, and plant cells; fungicides |
| 05/23/2006 | US7049420 Using gene product; polynucleotides; antitumor, anticancer agent |
| 05/23/2006 | US7049412 Genetic engineered nucleic acids codes these enzymes; therapy for bone disorders; monoclonal antibodies |
| 05/23/2006 | US7049407 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 05/23/2006 | US7049400 Detection protease activity during apoptosis; genetic engineeringl |
| 05/23/2006 | US7049395 For therapy of inflammatory disorders |
| 05/23/2006 | US7049136 Redirection of cellular immunity by receptor chimeras |
| 05/23/2006 | US7049126 Human serine protease |
| 05/23/2006 | US7049125 EGVIII endoglucanase and nucleic acids encoding the same |
| 05/23/2006 | US7049124 Hyaluronidase from the Hirudinaria manillensis isolation, purification and recombinant method of production |
| 05/23/2006 | US7049123 Deoxyribonuclease, gene encoding same and use thereof |
| 05/23/2006 | US7049122 Mutant-type lipases and applications thereof |
| 05/23/2006 | US7049121 For therapy of cocaine-induced condition; cocaine hydrolysis activity |
| 05/23/2006 | US7049120 Regulation of human mrp5-like protein |
| 05/23/2006 | US7049119 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/23/2006 | US7049118 isolated and purified protein and complimentary DNA; culturing a host cell to express the regulatory protein; biodrugs; enzyme inhibitors; anticarcinogenic, antidiabetic agents; nervous system disorders; chronic obstructive pulmonary disorder |
| 05/23/2006 | US7049117 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes |
| 05/23/2006 | US7049116 Genetically engineered enzyme for use in the treatment of cell proliferative disorders |
| 05/23/2006 | US7049115 Genes encoding denitrification enzymes |
| 05/23/2006 | US7049114 Glucose dehydrogenase |
| 05/23/2006 | US7049113 to the luciferin-luciferase reaction system; culturing a host cell, isolation of the protein; genetic engineering; improved durability of luminescence |
| 05/23/2006 | US7049112 Comprise CPRA protein (cytochrome enzyme complexes) for bioynthesis of long chain aliphatic dioic acids |
| 05/23/2006 | US7049111 hydroxymethylglutaryl coenzyme A reductase; isolated DNA; recombinant DNA vector; transformed cell; culturing the transformed cell to produce a hydroxylase; hydroxylation, separation; anticholesterol agents |
| 05/23/2006 | US7049108 Processes for producing lactic acid using yeast transformed with a gene encoding lactate dehydrogenase |
| 05/23/2006 | US7049106 Generation of preferential amino acid for use in medicine, and animal feeds; prepare nutrient broths, propagate, ferment amino acids, recover preferential amino acids |
| 05/23/2006 | US7049101 Enzymes having high temperature polymerase activity and methods of use thereof |
| 05/23/2006 | US7049100 Multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 05/23/2006 | US7049097 Antibiotics-independent vector for constant high-expression and method for gene expression using the same |
| 05/23/2006 | US7049092 drug screening for male antifertility agents by screening for inhibitors of said lipase which would have spermatogenesis inhibiting activity |
| 05/23/2006 | US7049091 14815, a human kinase family member and uses therefor |
| 05/23/2006 | US7049089 Respiratory system disorders; cardiovascular disorders; controlling signal transduction |
| 05/23/2006 | US7049088 PRMTs as modifiers of the p53 pathway and methods of use |
| 05/23/2006 | US7049075 Deoxyribonuclease IIβ proteins and cDNAs |
| 05/23/2006 | US7049062 Assay for methylation in the GST-Pi gene |
| 05/23/2006 | US7049058 Methods for suppressing the induction of nitric oxide synthase in a cell |
| 05/23/2006 | US7048923 Antibodies to mitogenic oxygenases |
| 05/23/2006 | US7048914 Placental alkaline phosphatase to control diabetes |
| 05/23/2006 | CA2335305C A bioluminescence resonance energy transfer (bret) system and its use |
| 05/23/2006 | CA2075206C Production of recombinant polypeptides by bovine species and transgenic methods |
| 05/18/2006 | WO2006053313A2 Elaiophylin biosynthetic gene cluster |
| 05/18/2006 | WO2006053253A2 Recovery of proteins from insect larvae |
| 05/18/2006 | WO2006052914A2 Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | WO2006052912A2 Acyltransferase regulation to increase the percent of polyunsaturated fatty acids in total lipids and oils of oleaginous organisms |
| 05/18/2006 | WO2006052871A2 Docosahexaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | WO2006052870A2 High eicosapentaenoic acid producing strains of yarrowia lipolytica |
| 05/18/2006 | WO2006052824A2 A mortierella alpina glycerol-3-phosphate o-acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | WO2006052814A2 A mortierella alpina diacylglycerol acyltransferase for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
| 05/18/2006 | WO2006052807A2 A dna molecule of mortierella alpina lpaat homolog |
| 05/18/2006 | WO2006052754A2 Ammonium transporter promoter for gene expression in oleaginous yeast |
| 05/18/2006 | WO2006051729A1 Method of isolating p450 gene |
| 05/18/2006 | WO2006051545A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 05/18/2006 | WO2006051387A1 Method of producing a carnitine-synthesising micro-organism |
| 05/18/2006 | WO2006051172A1 Method for testing a compound for a therapeutic effect and a diagnostic method |
| 05/18/2006 | WO2006050584A1 Endo-n-acetyl-beta-d-glucosaminidase enzymes of filamentous fungi |
| 05/18/2006 | WO2006032436A3 Use of microproteins as tryptase inhibitors |
| 05/18/2006 | WO2006012902A3 Creation of diversity in polypeptides |
| 05/18/2006 | WO2005123760A3 Treating cancer |
| 05/18/2006 | WO2005118840A3 Diagnostics and therapeutics for diseases associated with kallikrein 10 (klk10) |
| 05/18/2006 | WO2005116230A3 Golgi apparatus regenerated in vitro method for production and use thereof |
| 05/18/2006 | WO2005113587A3 Gene products expressed differentially in tumors and use thereof |
| 05/18/2006 | WO2005077117A3 Transgenic corn seed with enhanced amino acid content |
| 05/18/2006 | WO2005001112A3 RIBOSOMAL RNA METHYLTRANSFERASES R1mA: TARGET VALIDATION AND PROCESSES FOR DEVELOPING AN INHIBITOR ASSAY AND IDENTIFICATION CANDIDATE INHIBITORS |
| 05/18/2006 | WO2004074445A3 Model for studying the role of genes in tumor resistance to chemotherapy |
| 05/18/2006 | WO2004072238A3 Terminal-phosphate-labeled nucleotides with new linkers |
| 05/18/2006 | US20060107353 Plant bioreactors |
| 05/18/2006 | US20060107352 Transgenic expression cassettes for expression of nucleic acids in the plant blooms |
| 05/18/2006 | US20060107350 Fatty acid elongases |
| 05/18/2006 | US20060107340 Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto |
| 05/18/2006 | US20060106207 3-phosphoglycerate dehydrogenase having a reduced feedback inhibition by L-serine; produced by deleting at least 79 amino acids at the C terminus of the wild-type serA sequence |
| 05/18/2006 | US20060106204 Bifunctional energy-reversible acyl-compositions |
| 05/18/2006 | US20060106196 treatment or prophylaxis of cancer using proteins or peptides that elicit T cell mediated immunity; vaccination |
| 05/18/2006 | US20060106120 Method of degrading plastic and process for producing useful substance using the same |
| 05/18/2006 | US20060105943 Administering cyclic peptides; arthritis, inflammations, osteoporosis, retinopathies, contraception |
| 05/18/2006 | US20060105935 Lipase powder, methods for producing the same and use thereof |
| 05/18/2006 | US20060105914 Plant wall degradative compounds and systems |
| 05/18/2006 | US20060105459 Transgenic mice containing NTTP1 phosphatase gene disruptions |
| 05/18/2006 | US20060105445 Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins |
| 05/18/2006 | US20060105444 O-fucosyltransferase |
| 05/18/2006 | US20060105442 Promoters and proteins from Clostridium thermocellum and uses thereof |
| 05/18/2006 | US20060105438 1,3-Specific lipase powder, methods for producing the same and use thereof |
| 05/18/2006 | US20060105436 Immunosuppressant selected from prolyl-rapamycin, 4-hydroxy-prolyl-rapamycin, 4-hydroxyprolyl-26-demethoxy-rapamycin, 3-hydroxy-prolyl-rapamycin, 3-hydroxy-prolyl-26-demethoxy-rapamycin, and trans-3-aza-bicyclo[3,1,0]hexane-2-carboxylic acid rapamycin |
| 05/18/2006 | US20060105434 R-hydroxynitrillyases havign improved substrate tolerance and the use thereof |
| 05/18/2006 | US20060105432 Method for the production of vitamin b12 |
| 05/18/2006 | US20060105431 Fluorescein diglucuronide, trifluoromethylumbelliferyl glucuronide, or 4-methylumbelliferyl N-acetylglucosamine; GAG lyases from Pasteurella multocida in a reaction medium with a sugar precursor selected from uridine diphosphate (UDP)-glucosamine, UDP-N-acetylglucosamine, or UDP-N-acetylgalactosamine |
| 05/18/2006 | US20060105430 cleaving a heparin-like glycosaminoglycan using modified heparinases having altered binding specificity and activity; angiogenesis inhibition |
| 05/18/2006 | US20060105429 Nucleic acid encoding protein which comprises hormone and has higher plasma stability; maintains biological activity for prolonged period in body |
| 05/18/2006 | US20060105428 Alkaline protease |
| 05/18/2006 | US20060105427 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/18/2006 | US20060105425 Aspergillus niger promoter for expressing genes in host cells |
| 05/18/2006 | US20060105423 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 05/18/2006 | US20060105417 Stable cytochrome p450 24 (cyp24) expressing cell line and methods and uses thereof |
| 05/18/2006 | US20060105413 For modulating NF- kappa B signaling |
| 05/18/2006 | US20060105386 17867, a novel human aminopeptidase |
| 05/18/2006 | US20060105379 Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29 |
| 05/18/2006 | US20060105378 Tenascin-C nucleic acid ligands |
| 05/18/2006 | US20060105374 RhoB variants and methods of use |
| 05/18/2006 | US20060105327 Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma |